Rising Pharma Holding, Inc.
East Brunswick, NJ, United States
This page shows every FDA and USDA recall linked to Rising Pharma Holding, Inc.. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
7
Total Recalls
2023
First Recall
2025
Most Recent
Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Ris...
Oct 22, 2025
· Drug
Class II
Ongoing
Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, L...
Mar 26, 2025
· Drug
Class II
Ongoing
Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holding...
Jan 15, 2025
· Drug
Class II
Ongoing
Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90)...
Dec 11, 2024
· Drug
Class II
Ongoing
Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA...
Jul 17, 2024
· Drug
Class III
Ongoing
Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Bru...
Jun 12, 2024
· Drug
Class III
Ongoing
buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for:...
Jan 17, 2024
· Drug
Class II
Ongoing